Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1909 1
1911 1
1949 1
1950 1
1958 1
1960 1
1961 1
1962 1
1964 1
1965 3
1966 1
1967 3
1968 1
1969 2
1970 2
1971 2
1972 4
1974 1
1975 1
1976 2
1977 4
1978 4
1979 8
1980 4
1981 3
1983 4
1984 1
1985 2
1986 6
1987 4
1988 1
1989 1
1990 3
1991 1
1992 1
1994 1
2002 2
2003 3
2005 1
2006 2
2007 3
2009 4
2010 1
2011 2
2012 2
2013 1
2014 1
2015 7
2016 2
2019 2
2020 6
2021 6
2022 4
2023 5
2024 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

132 results

Results by year

Filters applied: . Clear all
Page 1
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets.
Souers AJ, Leverson JD, Boghaert ER, Ackler SL, Catron ND, Chen J, Dayton BD, Ding H, Enschede SH, Fairbrother WJ, Huang DC, Hymowitz SG, Jin S, Khaw SL, Kovar PJ, Lam LT, Lee J, Maecker HL, Marsh KC, Mason KD, Mitten MJ, Nimmer PM, Oleksijew A, Park CH, Park CM, Phillips DC, Roberts AW, Sampath D, Seymour JF, Smith ML, Sullivan GM, Tahir SK, Tse C, Wendt MD, Xiao Y, Xue JC, Zhang H, Humerickhouse RA, Rosenberg SH, Elmore SW. Souers AJ, et al. Among authors: phillips dc. Nat Med. 2013 Feb;19(2):202-8. doi: 10.1038/nm.3048. Epub 2013 Jan 6. Nat Med. 2013. PMID: 23291630
BCL-XL-targeting antibody-drug conjugates are active in preclinical models and mitigate on-mechanism toxicity of small-molecule inhibitors.
Judd AS, Bawa B, Buck WR, Tao ZF, Li Y, Mitten MJ, Bruncko M, Catron N, Doherty G, Durbin KR, Enright B, Frey R, Haasch D, Haman S, Haight AR, Henriques TA, Holms J, Izeradjene K, Judge RA, Jenkins GJ, Kunzer A, Leverson JD, Martin RL, Mitra D, Mittelstadt S, Nelson L, Nimmer P, Palma J, Peterson R, Phillips DC, Ralston SL, Rosenberg SH, Shen X, Song X, Vaidya KS, Wang X, Wang J, Xiao Y, Zhang H, Zhang X, Blomme EA, Boghaert ER, Kalvass JC, Phillips A, Souers AJ. Judd AS, et al. Among authors: phillips dc. Sci Adv. 2024 Oct 4;10(40):eado7120. doi: 10.1126/sciadv.ado7120. Epub 2024 Oct 4. Sci Adv. 2024. PMID: 39365864 Free PMC article.
X-ray studies of crystalline proteins.
North AC, Phillips DC. North AC, et al. Among authors: phillips dc. Prog Biophys Mol Biol. 1969;19(1):1-132. doi: 10.1016/0079-6107(69)90003-0. Prog Biophys Mol Biol. 1969. PMID: 4988891 Review. No abstract available.
MCL1 nuclear translocation induces chemoresistance in colorectal carcinoma.
Fu D, Pfannenstiel L, Demelash A, Phoon YP, Mayell C, Cabrera C, Liu C, Zhao J, Dermawan J, Patil D, DeVecchio J, Kalady M, Souers AJ, Phillips DC, Li X, Gastman B. Fu D, et al. Among authors: phillips dc. Cell Death Dis. 2022 Jan 18;13(1):63. doi: 10.1038/s41419-021-04334-y. Cell Death Dis. 2022. PMID: 35042842 Free PMC article.
Protein-oligosaccharide interactions: lysozyme, phosphorylase, amylases.
Johnson LN, Cheetham J, McLaughlin PJ, Acharya KR, Barford D, Phillips DC. Johnson LN, et al. Among authors: phillips dc. Curr Top Microbiol Immunol. 1988;139:81-134. doi: 10.1007/978-3-642-46641-0_4. Curr Top Microbiol Immunol. 1988. PMID: 2461836 Review. No abstract available.
CRYSTAL STRUCTURE OF N-ACETYLGLUCOSAMINE.
JOHNSON LN, PHILLIPS DC. JOHNSON LN, et al. Among authors: phillips dc. Nature. 1964 May 9;202:588. doi: 10.1038/202588a0. Nature. 1964. PMID: 14195059 No abstract available.
132 results